Liang Y - Search Results

1

PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade.

Peng Q, Qiu X, Zhang Z, Zhang S, Zhang Y, Liang Y, Guo J, Peng H, Chen M, Fu YX, Tang H. Peng Q, et al. Among authors: liang y. Nat Commun. 2020 Sep 24;11(1):4835. doi: 10.1038/s41467-020-18570-x. Nat Commun. 2020. PMID: 32973173 Free PMC article.

2

A dendritic-cell-stromal axis maintains immune responses in lymph nodes.

Kumar V, Dasoveanu DC, Chyou S, Tzeng TC, Rozo C, Liang Y, Stohl W, Fu YX, Ruddle NH, Lu TT. Kumar V, et al. Among authors: liang y. Immunity. 2015 Apr 21;42(4):719-30. doi: 10.1016/j.immuni.2015.03.015. Immunity. 2015. PMID: 25902483 Free PMC article.

3

Innate Lymphoid Cells Control Early Colonization Resistance against Intestinal Pathogens through ID2-Dependent Regulation of the Microbiota.

Guo X, Liang Y, Zhang Y, Lasorella A, Kee BL, Fu YX. Guo X, et al. Among authors: liang y. Immunity. 2015 Apr 21;42(4):731-43. doi: 10.1016/j.immuni.2015.03.012. Immunity. 2015. PMID: 25902484 Free PMC article.

4

Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication.

Liang Y, Yang K, Guo J, Wroblewska J, Fu YX, Peng H. Liang Y, et al. Sci Rep. 2015 May 20;5:10406. doi: 10.1038/srep10406. Sci Rep. 2015. PMID: 25993659 Free PMC article.

5

Deficiency of CD40 Reveals an Important Role for LIGHT in Anti-Leishmania Immunity.

Okwor I, Xu G, Tang H, Liang Y, Fu YX, Uzonna JE. Okwor I, et al. Among authors: liang y. J Immunol. 2015 Jul 1;195(1):194-202. doi: 10.4049/jimmunol.1401892. Epub 2015 May 29. J Immunol. 2015. PMID: 26026056

6

STING-cytosolic DNA sensing: the backbone for an effective tumor radiation therapy.

Liang Y, Peng H. Liang Y, et al. Ann Transl Med. 2016 Feb;4(3):60. doi: 10.3978/j.issn.2305-5839.2015.12.48. Ann Transl Med. 2016. PMID: 26904582 Free PMC article. No abstract available.

7

Androgen receptor antagonists compromise T cell response against prostate cancer leading to early tumor relapse.

Pu Y, Xu M, Liang Y, Yang K, Guo Y, Yang X, Fu YX. Pu Y, et al. Among authors: liang y. Sci Transl Med. 2016 Apr 6;8(333):333ra47. doi: 10.1126/scitranslmed.aad5659. Sci Transl Med. 2016. PMID: 27053771

8

CTLA-4 Limits Anti-CD20-Mediated Tumor Regression.

Ren Z, Guo J, Liao J, Luan Y, Liu Z, Sun Z, Liu X, Liang Y, Peng H, Fu YX. Ren Z, et al. Among authors: liang y. Clin Cancer Res. 2017 Jan 1;23(1):193-203. doi: 10.1158/1078-0432.CCR-16-0040. Epub 2016 Jun 27. Clin Cancer Res. 2017. PMID: 27354469 Free PMC article.

9

LIGHTing tumor up for checkpoint blockade.

Liang Y, Peng H. Liang Y, et al. Oncotarget. 2016 Aug 2;7(31):48857-48858. doi: 10.18632/oncotarget.10531. Oncotarget. 2016. PMID: 28004636 Free PMC article. No abstract available.

10

PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression.

Tang H, Liang Y, Anders RA, Taube JM, Qiu X, Mulgaonkar A, Liu X, Harrington SM, Guo J, Xin Y, Xiong Y, Nham K, Silvers W, Hao G, Sun X, Chen M, Hannan R, Qiao J, Dong H, Peng H, Fu YX. Tang H, et al. Among authors: liang y. J Clin Invest. 2018 Feb 1;128(2):580-588. doi: 10.1172/JCI96061. Epub 2018 Jan 16. J Clin Invest. 2018. PMID: 29337303 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

23,089 results

Search Page

Filters